ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025
Tuberculosis rates in migrants in low-incidence European countries, according to country of origin, reporting country and recency of immigration, 2014 to 2020.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Tuberculosis disease and infection screening among migrants in the Netherlands 2019-2023: a national retrospective observational study.The Lancet regional health. Europe · 2026Article
- National Inpatient Burden, Treatment Patterns, and In-Hospital Mortality of Spinal Tuberculosis in Germany Amid Demographic Change: A Population-Based DRG Study, 2019-2025.Global spine journal · 2026Article
- Patterns and drivers of the distribution of Leishmania infection in humans using environmental and socioeconomic factors: a modeling study in mainland Portugal.Parasites & vectors · 2026Article
- Differences found in patient characteristics of migrant tuberculosis sub-populations within low TB incidence European countries, 2014-2020.BMC infectious diseases · 2025Article
- Letter to the editor: Migrant tuberculosis in low-incidence Japan; introduction of pre-entry screening.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Authors' response: Migrant tuberculosis in low-incidence Japan; introduction of pre-entry screening.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundAs tuberculosis (TB) incidence rates decrease faster in native than migrant populations in European countries, addressing migrant health becomes increasingly important in TB programmes.AimTo inform European TB prevention and control policies, we analysed data on TB in migrants in low TB-incidence European countries (TB incidence < 10/100,000 population) during 2014-2020 by migrant origin, destination, and recent vs non-recent immigration.MethodsData on migrant TB patients were derived from the European Surveillance System (TESSy) and data on migrant populations from Eurostat or national statistical offices. We calculated annual migrant TB crude incidence rates (CIRs) per country of origin, destination country and year, for all migrants with TB and recently arrived migrants with TB, the latter defined by TB diagnosis within 1 year after arrival in the destination country.ResultsIn 2014-2020, 104,371 migrants with TB were reported to TESSy by 20 destination countries. Average annual migrant CIRs were highest in the United Kingdom (43/100,000). Origin countries of most migrant TB patients were India (n = 9,561), Romania (n = 8,345), and Pakistan (n = 7,300). The highest CIRs were found among migrants from Eritrea (480/100,000), Somalia (414/100,000) and The Gambia (343/100,000), and were higher than estimated World Health Organization incidences for those countries. The CIRs among recently arrived migrants appeared higher than in the overall migrant population.ConclusionsWe found substantially higher CIRs in certain migrant subpopulations than others. TB rates in recent migrants appeared to be up to 11 times higher than in corresponding origin countries. Tailored and regularly adapted TB prevention and control strategies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.